SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-211548
Filing Date
2024-09-03
Accepted
2024-09-03 07:47:30
Documents
18
Period of Report
2024-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d873622d8k.htm   iXBRL 8-K 44958
2 EX-4.2 d873622dex42.htm EX-4.2 26847
3 EX-10.1 d873622dex101.htm EX-10.1 812755
4 EX-10.2 d873622dex102.htm EX-10.2 350173
5 EX-10.3 d873622dex103.htm EX-10.3 51329
6 EX-99.1 d873622dex991.htm EX-99.1 12109
  Complete submission text file 0001193125-24-211548.txt   1714331

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ebs-20240830.xsd EX-101.SCH 2873
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20240830_lab.xml EX-101.LAB 17234
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20240830_pre.xml EX-101.PRE 10828
20 EXTRACTED XBRL INSTANCE DOCUMENT d873622d8k_htm.xml XML 3505
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 241271971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)